GLOBAL RESEARCH ARCHIVE
Citi - One Foot in Front of the Other
Research evidence excerpt
Citi - One Foot in Front of the Other
Truist Securities
Equity Research Report July 1, 2026
FINANCIALS: Universal Banks Citigroup Inc. (C)
Citi - One Foot in Front of the Other John McDonald
212-303-4179
John.McDonald@truist.com
We review the Citi thesis and set-up for the shares ahead of 2Q26 results. The biggest
investor discussion point in our catch-up conversations has been around valuation after
Peter Nicolo three years of outperformance, which now has Citi trading at a P/E premium to peers 212-303-4141
Peter.Nicolo@truist.com (11.6x vs. 11.0x) and 1.4x P/TBV against a near-term outlook for 11-13% ROTCE. Investors
continue to debate the burden of proof on Citi, which is expected to drive multiple years
of ROTCE expansion, efficiency improvement, and capital optimization, as well as whether John Manahan higher EPS growth expectations (and self-help drivers) are sufficient to justify a P/E premium 212-303-4158
John.Manahan@truist.com and some "advance credit" on P/TBV.
Highly Confident in ROTCE Commitment: On the recent conference circuit, CFO Gonzalo
Stock Rating BUY Luchetti expressed a high degree of confidence in delivering its 10-11% ROTCE target for this year, and the ~60% efficiency ratio commitment inside of that, on the way to higher Unchanged
returns over time. As Citi outlined at its May investor day (our recap here), ROTCE should
Price Target $158.00 trend up to a range of 11-13% over the near-term (i.e. 2027/2028), towards the high end of
Unchanged that range by 2028, and then 14-15% over the "medium term" (i.e. 2029-2031), driven at a
high-level by a) client momentum, b) structural efficiency gains, and c) capital productivity
via DTA utilization. Citi assumes that CET-1 trends higher to a target of 13.1% by 2028 (vs.
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer